SCHEMBL4495992

SCHEMBL4495992

Fc1cc(NCCc2c(Cl)ncnc2Cl)c(F)cc1Br

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12414224 0.71 PKM (0.42)
SCHEMBL4491773 0.65 IDH1 (0.40) RAB9A
SCHEMBL4497189 0.64 GALR3 (0.38) RAB9A
SCHEMBL30562904 0.62 PDE4A (0.41)
SCHEMBL21456839 0.62 PDE4A (0.41)
SCHEMBL2621720 0.62 PDE4A (0.41)
SCHEMBL24669962 0.60 NPC1 (0.43) NPC1RAB9A
SCHEMBL3234702 0.59 CA1 (0.42) NPC1RAB9A
SCHEMBL23862938 0.59 AURKA (0.55)
SCHEMBL505780 0.59 KDM1A (0.48) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222261-B2 Chemical compounds GlaxoSmithKline, LLC (US) 2012-07-17 US disclosed
US-20090318477-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318477-A1 CHEMICAL COMPOUNDS GPR119, GOT2, SLC5A2 NPC1 232/4885RAB9A 2526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.